Sale of 2,500 shares at $16.4566 per share.
Reporting Person Stengone Carmine N. · Officer Title CEO and President · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001628280-26-060962 · filed 2026-09-08 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Contineum Therapeutics, Inc. (CTNM)." Disclosed 2026-09-08. https://desqlong.com/cards/0001628280-26-060962-2 (retrieved 2026-09-26).